1,195 results on '"Won, Jong-Ho"'
Search Results
152. Is immunological recovery clinically relevant at 100 days after allogeneic transplantation?
153. CO 2 Reduction: Atomic‐Scale Spacing between Copper Facets for the Electrochemical Reduction of Carbon Dioxide (Adv. Energy Mater. 10/2020)
154. Atomic‐Scale Spacing between Copper Facets for the Electrochemical Reduction of Carbon Dioxide
155. A Case of Donor Cell Leukemia after Allogenic Peripheral Blood Stem Cell Transplantation for Acute Promyelocytic Leukemia with PML-RARA
156. Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study
157. Influence of Visual Deprivation on Auditory Spectral Resolution, Temporal Resolution, and Speech Perception
158. Re-analysis of the Outcomes of Post-Remission Therapy for Acute Myeloid Leukemia with Core Binding Factor According to Years of Patient Enrolment
159. Posaconazole versus Itraconazole as Prophylactic Antifungal Agents during Induction Chemotherapy for Acute Myeloid Leukemia: A Real-World Single Center Comparison
160. Sensitivity of psychophysical measures to signal processor modifications in cochlear implant users
161. Relapsed or refractory nongastric marginal zone B-cell lymphoma: Multicenter retrospective analysis of 92 cases
162. Enhancement of Catalytic Activity and Selectivity for the Gaseous Electroreduction of CO2 to CO: Guidelines for the Selection of Carbon Supports.
163. NON-INVASIVELY MONITORING TRANSPLANTED STEM CELLS IN THE CAVERNOUS NERVE INJURED CORPORA CAVERNOSA OF RATS USING THE MOLECULAR MAGNETIC RESONANCE IMAGING: 2 Podium
164. Bortezomib and the Increased Incidence of Herpes Zoster in Patients with Multiple Myeloma
165. Improving performance in noise for hearing aids and cochlear implants using coherent modulation filtering
166. Successful Eradication of Relapsed Primary Effusion Lymphoma with High-Dose Chemotherapy and Autologous Stem Cell Transplantation in a Patient Seronegative for Human Immunodeficiency Virus
167. Erratum to: Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant
168. Magnetic resonance evaluation of human mesenchymal stem cells in corpus cavernosa of rats and rabbits
169. 524 - Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) As Conditioning Therapy for Autologous Transplantation in Patients with Relapsed or High Risk Non-Hodgkin Lymphoma: A Multicenter Randomized Phase II Study By the Consortium for Improving Survival of Lymphoma (CISL)
170. Status and Developmental Direction of Persistent Pollutants Survey on Marine Ecosystems of Korea
171. Residual Life-Time Evaluation Method Using Instrumented Indentation Test
172. A phase II trial of bendamustine, carboplatin, and dexamethasone for refractory or relapsed peripheral T-cell lymphoma (BENCART trial)
173. Graphene Pliable Pockets Remedying Nanocrystalline Metal Anode for All Li-Ion Types Energy Storages Induced By Polymer-Triggered Synthesis Process in an Expeditious, Scalable and Inexpensive Way
174. Bortezomib Is More Effective to Side Population of RPMI8226 Myeloma Cells than Classical Anti-myeloma Agents
175. Allogeneic Stem Cell Transplantation for Patients with Natural Killer/T Cell Lymphoid Malignancy: A Multicenter Analysis Comparing Upfront and Salvage Transplantation
176. microRNA-22 and TET-2 Mutation in Myelodysplastic Syndrome Patients Treated with Hypomethylating Agents
177. Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study
178. Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis
179. Effect of Stem Cell Source and Dose on Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Idiopathic Aplastic Anemia: Data from the Korean Aplastic Anemia Trials.
180. Association Between c-Met and Lymphangiogenic Factors in Patients With Colorectal Cancer
181. Frequency-Limiting Effects on Speech and Environmental Sound Identification for Cochlear Implant and Normal Hearing Listeners
182. The incidence of venous thromboembolism is not lowin Korean patients with advanced pancreatic cancer
183. Assessment of a new genomic classification system in acute myeloid leukemia with a normal karyotype
184. Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma
185. Neural encoding of vowel formant frequency in normal-hearing listeners
186. Erratum: Effects of age and hearing mechanism on spectral resolution in normal hearing and cochlear-implanted listeners [J. Acoust. Soc. Am. 141(1), 613–623 (2017)]
187. Becoming a Co-operative with Self-Organizing Process : The case of Happy Bridge Co-operative
188. Optimal Timing of Second Transplant in Myeloma Patients Without Optimal Response to First Transplant
189. Capacitors: Synthesis of Nitrogen-Rich Nanotubes with Internal Compartments having Open Mesoporous Channels and Utilization to Hybrid Full-Cell Capacitors Enabling High Energy and Power Densities over Robust Cycle Life (Adv. Energy Mater. 1/2017)
190. Effects of age and hearing mechanism on spectral resolution in normal hearing and cochlear-implanted listeners
191. Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort
192. 5-Hydroxymethylcytosine correlates with epigenetic regulatory mutations, but may not have prognostic value in predicting survival in normal karyotype acute myeloid leukemia
193. Speech perception in children with cochlear implants for continua varying in formant transition duration
194. Predictors of General Discomfort, Limitations in Activities of Daily Living, and Intention of a Second Donation in Unrelated Hematopoietic Stem Cell Donation
195. Randomized Phase II Multi-Center Trial of Busulfan, Etoposide, and Cyclophosphamide Versus Busulfan, Etoposide, and Melphalan As Conditioning Therapy for Autologous Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from Consortium for Improving Survival of Lymphoma (CISL)
196. Phase II Trial of R-CVP Followed By Rituximab Maintenance Therapy for Patients with Advanced Stage Marginal Zone Lymphoma- Consortium for Improving Survival of Lymphoma (CISL) Study
197. Longitudinal Tracking of MDS Patients Using Next Generation Sequencing Provides a Predictive Measure for Azacitidine Response and AML Progression
198. A Phase II Trial of Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-Cell Lymphoma (BENCART): A Consortium for Improving Survival of Lymphoma (CISL) Trial
199. Replication of New Genomic Classification System in Acute Myeloid Leukemia with Normal Karyotype
200. RUNX1 Mutation in Cytogenetically Normal Acute Myeloid Leukemia : Clinical Implications, Co-Mutation Analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.